A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Genentech, Inc.
Bristol-Myers Squibb
National Cancer Institute (NCI)
Providence Health & Services
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
KaliVir Immunotherapeutics
Eastern Cooperative Oncology Group
Aulos Bioscience, Inc.
Ipsen
AstraZeneca
Pfizer
Pfizer
Stanford University
AstraZeneca
Mayo Clinic
Neonc Technologies, Inc.
ViroMissile, Inc.
Washington University School of Medicine
Radiopharm Theranostics, Ltd
Arvinas Inc.
Tizona Therapeutics, Inc
Daiichi Sankyo
DualityBio Inc.
MacroGenics
Daiichi Sankyo
University of Nebraska
Natera, Inc.
Elephas
Innate Pharma
The Netherlands Cancer Institute
Elephas
OncoNano Medicine, Inc.
Degron Therapeutics Co.
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University Health Network, Toronto
Cancer Research UK
LG Chem
West China Hospital
DualityBio Inc.
Massive Bio, Inc.
Memorial Sloan Kettering Cancer Center
ImmVira Pharma Co. Ltd
Memgen, Inc.
Guardant Health, Inc.
Azienda Ospedaliera di Padova